SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Avicena Group, Inc. Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis